Review
Nedocromil sodium: a review of clinical studies
Affiliations
- PMID: 2553034
Item in Clipboard
Review
Nedocromil sodium: a review of clinical studies
Eur Respir J Suppl.
1989 Jun.
Abstract
Nedocromil sodium is a new compound for the long-term treatment of bronchial asthma. Its effect has been studied in prevention of bronchospasm induced by a variety of stimuli showing a broader spectrum of activity than SCG. Its clinical efficacy has been demonstrated in a number of trials involving patients regardless of asthma type.
Similar articles
-
Clinical evaluation of nedocromil sodium in asthma.Br J Clin Pract Suppl. 1987 Nov;53:13-21. Br J Clin Pract Suppl. 1987. PMID: 2849474 Review. No abstract available.
-
[Basic research on nedocromil sodium].Rev Mal Respir. 1992;9 Suppl 1:R93-7. Rev Mal Respir. 1992. PMID: 1317052 Review. French.
-
Nedocromil sodium (Tilade): a review of preclinical studies.Eur Respir J Suppl. 1989 Jun;6:561s-565s. Eur Respir J Suppl. 1989. PMID: 2553033 Review.
-
[Sodium-nedocromil. A new anti-inflammatory agent for the treatment of asthma].Ugeskr Laeger. 1991 Dec 9;153(50):3568-70. Ugeskr Laeger. 1991. PMID: 1663671 Danish. No abstract available.
-
[Comparison of the effects of sodium cromoglycate and nedocromil sodium. II].Rev Alerg Mex (1987). 1988 Sep-Oct;35(4):84-8. Rev Alerg Mex (1987). 1988. PMID: 2855379 Review. Spanish. No abstract available.
Cited by
-
Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects.Br J Pharmacol. 1992 Feb;105(2):436-40. doi: 10.1111/j.1476-5381.1992.tb14271.x. Br J Pharmacol. 1992. PMID: 1313729 Free PMC article.
-
Clinical pharmacology of asthma. Implications for treatment.Drugs. 1993 Nov;46(5):847-62. doi: 10.2165/00003495-199346050-00005. Drugs. 1993. PMID: 7507035 Review.
-
Mast cells and company.Front Immunol. 2012 Feb 20;3:16. doi: 10.3389/fimmu.2012.00016. eCollection 2012. Front Immunol. 2012. PMID: 22566901 Free PMC article.